Health · Healthcare & Policy · 1 hr ago
Australian inquiry to examine online sales of unapproved peptides
Australia’s federal government has ordered an inquiry into how peptides are prescribed and sold online.
Peptides are promoted for weight loss, muscle growth, recovery and anti-ageing, but many products have not been assessed by Australian regulators for safety or effectiveness.
The inquiry will look at telehealth businesses that can consult patients, prescribe medicines and deliver them without an in-person doctor’s visit.
Health authorities and doctors say people who obtain peptides through grey-market channels have experienced serious side effects, hospitalisation and sometimes permanent health problems.
The inquiry will examine whether safeguards keep pace with online businesses that combine medical advice and medicine sales, as well as social media promotion.
Hearings are expected to begin this month, with a final report due by mid-2027 that could lead to tighter rules.
Health Minister Mark Butler has ordered a federal parliamentary inquiry into the prescribing and sale of peptides in Australia.
The inquiry will examine online clinics, dispensaries and social media platforms involved in promoting or supplying peptide products.
Regulators warn that many products are unapproved and have not been assessed for safety or effectiveness in Australia.
The inquiry will also consider whether medical safeguards and enforcement systems can oversee newer online healthcare business models.
Consultation hearings are expected to begin this month, with a final report due by mid-2027.
- Who
- Health Minister Mark Butler ordered the inquiry. The House of Representatives health committee will conduct it.
- What
- A federal parliamentary inquiry into the prescribing and sale of peptides.
- When
- Ordered by November 21, 2026. Hearings are expected to begin this month, and the final report is due by mid-2027.
- Where
- Australia.
- Why
- To examine health risks from unapproved peptides and whether safeguards and enforcement systems can oversee online healthcare businesses.
This story does not have two clearly opposing sides.
The inquiry was requested in a letter to Labor MP Mike Freelander, chairman of the House of Representatives health committee.
Health Minister Mark Butler ordered an inquiry into the prescribing and sale of peptides.
Consultation hearings are expected to begin.
The inquiry is expected to deliver its final report.
- Inquiry subject
- Prescribing and sale of peptides
- Inquiry chair
- Mike Freelander, chairman of the House of Representatives health committee
- Expected hearings
- This month
- Expected final report
- Mid-2027
What people are saying
I know peptides are often marketed on social media as wonder-drugs, but the reality is that they can pose serious health risks to Australian consumers
I am extremely concerned about escalating reports by the TGA of unapproved peptides being prescribed and delivered via telehealth and one-stop-shop style dispensaries.
But just because someone with a six-pack is promoting something online doesn’t mean it’s safe